CTMX vs. SPY
Compare and contrast key facts about CytomX Therapeutics, Inc. (CTMX) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CTMX or SPY.
Correlation
The correlation between CTMX and SPY is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CTMX vs. SPY - Performance Comparison
Key characteristics
CTMX:
-0.20
SPY:
1.91
CTMX:
1.20
SPY:
2.57
CTMX:
1.17
SPY:
1.35
CTMX:
-0.48
SPY:
2.88
CTMX:
-0.68
SPY:
11.96
CTMX:
68.12%
SPY:
2.03%
CTMX:
234.39%
SPY:
12.68%
CTMX:
-97.78%
SPY:
-55.19%
CTMX:
-97.68%
SPY:
0.00%
Returns By Period
In the year-to-date period, CTMX achieves a -22.80% return, which is significantly lower than SPY's 4.34% return.
CTMX
-22.80%
-5.33%
-35.87%
-45.90%
-36.05%
N/A
SPY
4.34%
2.33%
10.15%
23.99%
14.44%
13.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CTMX vs. SPY — Risk-Adjusted Performance Rank
CTMX
SPY
CTMX vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for CytomX Therapeutics, Inc. (CTMX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CTMX vs. SPY - Dividend Comparison
CTMX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.16%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTMX CytomX Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.16% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
CTMX vs. SPY - Drawdown Comparison
The maximum CTMX drawdown since its inception was -97.78%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for CTMX and SPY. For additional features, visit the drawdowns tool.
Volatility
CTMX vs. SPY - Volatility Comparison
CytomX Therapeutics, Inc. (CTMX) has a higher volatility of 19.74% compared to SPDR S&P 500 ETF (SPY) at 3.13%. This indicates that CTMX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.